Operator: Welcome to HF Sinclair Corporations First Quarter 2025 Conference Call and Webcast. Hosting the call today is Tim ...

Shares of HF Sinclair Corp. DINO rose 2.37% to $32.01 Friday, on what proved to be an all-around great trading session for ...

Sinclair announced balance sheet refinancing in combination with joint venture agreement that may bring new IoT capabilities.

CFO Atanas Atanasov reported a quarterly net loss of $4 million, or (-$0.02) per share. Adjusted net loss was $50 million, or (-$0.27) per diluted share. Total adjusted EBITDA for Q1 2025 was $201 ...

Epigenetic reprogramming holds promise for reversing aging, addressing cellular aging mechanisms and paving the way for innovative therapeutic strategies.

GENEVA (AP) — Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs. The Basel-based company, ...

The pharmaceutical industry has a crucial role in modern healthcare, but it also has a significant environmental footprint. From large-scale solvent use and carbon emissions to water pollution and ...

Bank of America Securities analyst Tazeen Ahmad reiterated a Buy rating on Ascendis Pharma (ASND – Research Report) today and set a price target of $192.00. Discover outperforming stocks and ...

HERZLIYA, Israel and CALGARY, AB, April 15, 2025 /PRNewswire/ -- Innocan Pharma Corporation (the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that it has closed its ...

Iris Bincovich Innocan Pharma's CEO stated: "It is an honour to receive the continued support of our investors, who have placed their trust in Innocan's proprietary technology". The Company ...

Trump orders Medicare overhaul, seeking delayed price negotiations for pills, aligning rules with biologic drugs amid pharma industry pressure. Trump's executive order pushes Congress to delay drug ...

BERLIN, April 10, 2025--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment ...